All > Kidney Stone

Weight Loss for Kidney Stones

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Kidney StonesWeight Loss - Behavioral
Eligibility
21 - 99
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of a weight loss program with or without the drug Pio on obese people with type 2 diabetes.

Eligible Conditions
  • Kidney Stones

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Deferred group - pioglitazone
1
[18F]FLT-PET/CT
1
Weight Loss

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 24 weeks

24 weeks
Uric acid
Urine Ammonium/Net Acid Excretion
Urine Net Acid Excretion/Sulphate
Urine pH

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Deferred group - pioglitazone
1
[18F]FLT-PET/CT
1
Weight Loss

Trial Design

2 Treatment Groups

Pioglitazone Drug (including Placebo)
1 of 2
Weight Loss, Behavioral
1 of 2

Experimental Treatment

54 Total Participants · 2 Treatment Groups

Primary Treatment: Weight Loss · No Placebo Group · Phase 4

Pioglitazone Drug (including Placebo)
Drug
Experimental Group · 1 Intervention: Pioglitazone 45 mg · Intervention Types: Drug
Weight Loss, Behavioral
Behavioral
Experimental Group · 1 Intervention: Weight Loss · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Weight Loss
2008
Completed Phase 3
~1380
Pioglitazone
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
952 Previous Clinical Trials
607,870 Total Patients Enrolled
3 Trials studying Kidney Stones
505 Patients Enrolled for Kidney Stones
Khashayar Sakhaee, MDPrincipal Investigator - UTSW
Children's Medical Center of Dallas, The University of Texas Southwestern Medical Center At Dallas, UT Southwestern Medical Center-Zale Lipshy Campus
Shiraz University Of Medical Sci & Hlth Serv (Medical School)
Vet Affairs Medical Center (Residency)
3 Previous Clinical Trials
122 Total Patients Enrolled

Eligibility Criteria

Age 21 - 99 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top